Adjuvant chemotherapy with paclitaxel and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma

OBJECTIVE: No standard postoperative adjuvant chemotherapy has ever been established in node-positive esophageal squamous cell carcinoma (ESCC). This is a study to explore the effect of postoperative paclitaxel (PTX) and cisplatin (DDP) in lymph node-positive, completely resected thoracic ESCC patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Liangze, Li, Weiwei, Lyu, Xiao, Song, Yan, Mao, Yousheng, Wang, Shaoming, Huang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422417/
https://www.ncbi.nlm.nih.gov/pubmed/28536494
http://dx.doi.org/10.21147/j.issn.1000-9604.2017.02.08

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422417/
https://www.ncbi.nlm.nih.gov/pubmed/28536494
http://dx.doi.org/10.21147/j.issn.1000-9604.2017.02.08

Ejemplares similares